California DTSC Seeks Information On Nail-Care Product Content, ‘Green’ Alternatives

California’s Department of Toxic Substances Control is collecting data on nail product ingredients, impurities and purported “green” or “safer” alternatives via an information call-in, which could lead to Priority Product listings or support alternatives assessment activities under the state’s Safer Consumer Products regulation. Companies do not have to answer the call, but the DTSC will be posting a Response Status List.

Road trip to California, Red, white and blue interstate highway road sign with word California and map of California with sky background 3D Illustration

California’s Department of Toxic Substances Control is going straight to the source for data regarding nail products sold in the state via an information call-in, with a 20 December deadline for responses.

The DTSC, which administers the state’s Safer Consumer Products (SCP) program, already has proposed nail products containing toluene and nail products containing methyl methacrylate as potential Priority Products for alternatives assessments and, ultimately, bans, restrictions or other risk management measures

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

US Fragrance Firms Should Identify Domestic, Non-Tariff Sources Now – Fragrance House CEO

Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.

Cosmetics Consortium Shares Studies With FDA To Build Confidence In Animal Testing Alternatives

 
• By 

By guiding regulators through case studies and mock dossier examples of how to utilize new approach methodologies, the International Collaboration on Cosmetics Safety hopes to counter hesitations in replacing animal tests.

Stakeholders Hope US FDA’s Proposed Animal Test Phase-Out For Drugs Will Extend To OTCs, Cosmetics

 
• By 

The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.